Global Information
회사소개 | 문의

미용기기 : 의료기기 파이프라인 평가

Aesthetic Devices - Medical Devices Pipeline Assessment, 2018

리서치사 GlobalData
발행일 2018년 08월 상품 코드 351351
페이지 정보 영문 357 Pages
가격
US $ 4,000 ₩ 4,582,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,000 ₩ 9,164,000 PDF by E-mail (Site license) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 12,000 ₩ 13,746,000 PDF by E-mail (Global license) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


미용기기 : 의료기기 파이프라인 평가 Aesthetic Devices - Medical Devices Pipeline Assessment, 2018
발행일: 2018년 08월 페이지 정보 : 영문 357 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

미용기기(Aesthetic Devices)의 파이프라인 제품에 대해 조사했으며, 개발 단계별 동향과 주요 제품 개발 기업, 현재 지속중인 임상시험, 업계의 최근 동향 등의 정보를 전해드립니다.

제1장 목차

제2장 서론

  • 미용기기 개요

제3장 개발중인 제품

  • 파이프라인 제품 : 개발 단계별
  • 파이프라인 제품 : 부문별
  • 파이프라인 제품 : 지역(국가)별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 승인 시기별(추정)
  • 지속중인 임상시험

제4장 미용기기 - 개발중인 파이프라인 제품 : 기업별

  • 개발 기업 - 파이프라인 제품 : 개발 단계별
  • 파이프라인 제품 : 개발 단계별

제5장 미용기기 개발 기업과 제품 개요

  • Advalight
  • Aesthetic Medical Device
  • Aesthetics Point Ltd.
  • AirXpanders, Inc.
  • Allergan, Inc.
  • Ambicare Health Ltd
  • Andrew Technology, LLC
  • Anika Therapeutics, Inc.
  • Avita Medical Ltd
  • BioPhotas, Inc.
  • BioPolymer GmbH & Co. KG
  • Biosculpture Technology, Inc.
  • Body Organ Biomedical Corp.
  • Chromogenex Technologies Limited
  • Cozart plc
  • Cynosure, Inc.
  • Cytophil, Inc.
  • Cytori Therapeutics, Inc.
  • Cytosial Biomedic, S.a.s.
  • Dermele Skin Care, LLC
  • Ellman International, Inc.
  • Erchonia Corporation
  • Eternity Healthcare Inc.
  • EternoGen, LLC
  • Eve Aesthetics Ltd.
  • FibroGen, Inc.
  • Forticell Bioscience, Inc.
  • Genethia Phrima SRL
  • Genzyme Corporation
  • Ilooda Co., Ltd.
  • ImpLite Ltd.
  • Innovia LLC
  • Invasix
  • Juvenis Ltd.
  • Keraderm LLC
  • Khorionyx
  • L&C Bio
  • Medifirst Solutions, Inc.
  • Medixsysteme
  • Mentor Worldwide LLC
  • Merz Pharma GmbH & Co. KgaA
  • Moma Therapeutics, Inc.
  • Mosaic Medical Technologies, Inc
  • Neosthetic, LLC
  • NivaSonix, LLC
  • Northwestern University
  • Northwood Medical Innovation Limited
  • Nu Skin International Inc.
  • Oligo Medic, Inc.
  • ORGEV Laboratories
  • Osyris Medical
  • Philips Healthcare
  • PhotoDerma SA
  • PhotoMedex, Inc.
  • Pinnacle Therapeutics
  • PolyNovo Biomaterials Pty Ltd
  • PS Advanced Engineering
  • Rocky Mountain Biosystems Inc
  • SANUWAVE Health, Inc.
  • Sebacia Inc.
  • Sekisui Medical Co., Ltd.
  • SharpLight
  • Shin Poong Pharm.Co., Ltd.
  • Sinclair IS Pharma Plc
  • Slender Medical Ltd.
  • Suneva Medical, Inc.
  • Sybaritic, Inc.
  • Syneron Medical Ltd.
  • TEI Biosciences, Inc.
  • ThermiAesthetics
  • University of California, Irvine
  • Valeant Pharmaceuticals Ltd
  • Yolo Medical Inc.

제6장 미용기기 : 최근의 동향

제7장 부록

KSM 16.02.15

영문목차

GlobalData's Medical Devices sector report, "Aesthetic Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Aesthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Aesthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Aesthetic Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Aesthetic Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Aesthetic Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 9
  • 1.2 List of Figures 15

2 Introduction 16

  • 2.1 Aesthetic Devices Overview 16

3 Products under Development 17

  • 3.1 Aesthetic Devices - Pipeline Products by Stage of Development 17
  • 3.2 Aesthetic Devices - Pipeline Products by Segment 18
  • 3.3 Aesthetic Devices - Pipeline Products by Territory 19
  • 3.4 Aesthetic Devices - Pipeline Products by Regulatory Path 21
  • 3.5 Aesthetic Devices - Pipeline Products by Estimated Approval Date 23
  • 3.6 Aesthetic Devices - Ongoing Clinical Trials 24

4 Aesthetic Devices - Pipeline Products under Development by Companies 25

  • 4.1 Aesthetic Devices Companies - Pipeline Products by Stage of Development 25
  • 4.2 Aesthetic Devices - Pipeline Products by Stage of Development 28

5 Aesthetic Devices Companies and Product Overview 32

  • 5.1 Acelity L.P. Inc. Company Overview 32
  • 5.2 Aeon Astron Corporation Company Overview 33
  • 5.3 Aesthetic Medical Device Company Overview 34
  • 5.4 Aesthetics Point Ltd. Company Overview 36
  • 5.5 Allergan Inc Company Overview 37
  • 5.6 Allergan Plc Company Overview 39
  • 5.7 Almirall Ltd Company Overview 47
  • 5.8 Ambicare Health Ltd Company Overview 48
  • 5.9 Andrew Technology LLC Company Overview 49
  • 5.10 Anika Therapeutics Inc Company Overview 50
  • 5.11 Avita Medical Ltd Company Overview 51
  • 5.12 BioPhotas, Inc. Company Overview 54
  • 5.13 Biosculpture Technology, Inc. Company Overview 55
  • 5.14 BioTime Inc Company Overview 57
  • 5.15 Bioxis Pharmaceuticals Company Overview 61
  • 5.16 Bovie Medical Corp Company Overview 66
  • 5.17 Celltrix AB Company Overview 69
  • 5.18 CollPlant Ltd Company Overview 70
  • 5.19 Cutera Inc Company Overview 71
  • 5.20 Cytori Therapeutics Inc Company Overview 76
  • 5.21 Cytrellis Biosystems Inc Company Overview 77
  • 5.22 Dermele Skin Care, LLC Company Overview 80
  • 5.23 Eclipse Aesthetics LLC Company Overview 81
  • 5.24 Ellman International Inc Company Overview 82
  • 5.25 Emory University Company Overview 83
  • 5.26 Erchonia Corp Company Overview 84
  • 5.27 Eternity Healthcare Inc. Company Overview 85
  • 5.28 EternoGen Aesthetics LLC Company Overview 86
  • 5.29 Forticell Bioscience Inc Company Overview 87
  • 5.30 Fourth State Medicine Ltd Company Overview 88
  • 5.31 Genzyme Corp Company Overview 89
  • 5.32 ImpLite Ltd. Company Overview 90
  • 5.33 Innova Medical Design Company Overview 91
  • 5.34 Innovia LLC Company Overview 92
  • 5.35 IonMed Ltd. Company Overview 94
  • 5.36 Juvenis Ltd Company Overview 95
  • 5.37 Keraderm LLC Company Overview 96
  • 5.38 Khorionyx SA Company Overview 97
  • 5.39 Medifirst Solutions Inc Company Overview 98
  • 5.40 Medixsysteme Company Overview 100
  • 5.41 Merz Pharma GmbH & Co KgaA Company Overview 102
  • 5.42 Moma Therapeutics, Inc. Company Overview 104
  • 5.43 N8 Medical Inc Company Overview 105
  • 5.44 NanoVibronix Inc Company Overview 106
  • 5.45 Neosthetic, LLC Company Overview 107
  • 5.46 Northwestern University Company Overview 108
  • 5.47 Nu Skin International Inc. Company Overview 109
  • 5.48 Oligo Medic Inc Company Overview 111
  • 5.49 PetVivo Holdings Inc Company Overview 112
  • 5.50 PhotoDerma SA Company Overview 114
  • 5.51 PhotoMedex Inc Company Overview 116
  • 5.52 PhotoSonix Medical, Inc. Company Overview 118
  • 5.53 Pinnacle Therapeutics Company Overview 119
  • 5.54 PolyNovo Biomaterials Pty Ltd Company Overview 120
  • 5.55 PS Advanced Engineering Company Overview 123
  • 5.56 Regen Lab SA Company Overview 125
  • 5.57 Regenscientific Company Overview 128
  • 5.58 Samyang Biopharmaceuticals Corp Company Overview 129
  • 5.59 SANUWAVE Health Inc Company Overview 130
  • 5.60 Sebacia Inc Company Overview 133
  • 5.61 Sekisui Medical Co Ltd Company Overview 134
  • 5.62 Serene Medical, Inc. Company Overview 135
  • 5.63 Shanghai Haohai Biological Technology Co Ltd Company Overview 136
  • 5.64 Shin Poong PharmCo Ltd Company Overview 138
  • 5.65 Sienna Biopharmaceuticals Inc Company Overview 139
  • 5.66 Sinclair Pharma PLC Company Overview 142
  • 5.67 Slender Medical Ltd. Company Overview 149
  • 5.68 Sofregen Medical Inc Company Overview 151
  • 5.69 Southern Illinois University Carbondale Company Overview 152
  • 5.70 Syneron Medical Ltd Company Overview 153
  • 5.71 TEI Biosciences Inc Company Overview 154
  • 5.72 University of California Irvine Company Overview 155
  • 5.73 University of California Santa Barbara Company Overview 156
  • 5.74 Valeant Pharmaceuticals International Inc Company Overview 157
  • 5.75 Zeltiq Aesthetics Inc Company Overview 160

6 Aesthetic Devices- Recent Developments 162

  • 6.1 Jul 16, 2018: Cutera Launches truSculpt iD, Personalized Body Sculpting: The Next Evolution 162
  • 6.2 Jul 12, 2018: InMode Introduces Triton: The World's First and Only Simultaneous Multi-Wavelength Hair Removal 162
  • 6.3 Jul 09, 2018: Solsys Medical Appoints Dr. Arti Masturzo As Chief Medical Officer 163
  • 6.4 Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018 164
  • 6.5 Jul 02, 2018: Lumenis Unveils NuEra tight , Its High Power, Temperature-Controlled Top to Toe Radio Frequency Skin Laxity and Cellulite Treatment, at the 2018 Aesthetic Show 165
  • 6.6 Jun 25, 2018: Zimmer Biomet Update on Warsaw North Campus FDA Inspection 166
  • 6.7 Jun 19, 2018: STRATA Skin Sciences Announces 510(k) Submission for its Multi Micro Dose Tip Accessory for the XTRAC 308nm Excimer Laser 166
  • 6.8 Jun 12, 2018: AirXpanders Appoints Frank Grillo As New CEO 167
  • 6.9 Jun 11, 2018: Quantel Medical creates a new subsidiary in Poland 167
  • 6.10 Jun 06, 2018: InMode Aesthetic Solutions Launches A New Concept for Subdermal Adipose-Remodeling of the Face, EmbraceRF and Morpheus8 168
  • 6.11 Jun 06, 2018: Sciton Announces New HALO 2.0 and New FDA Indications 169
  • 6.12 Jun 04, 2018: SWAG Penis Enhancement Procedure Developed by Top Plastic Surgeon Achieving Optimal Results 169
  • 6.13 Jun 04, 2018: SANUWAVE Health Names Shri Parikh As President For Global Healthcare Division 170
  • 6.14 Jun 04, 2018: Viveve Announces Settlement of Patent Infringement Litigation with Thermi 171

7 Appendix 352

  • 7.1 Methodology 352
  • 7.2 About GlobalData 355
  • 7.3 Contact Us 355
  • 7.4 Disclaimer 355

1.1 List of Tables

  • Table 1: Aesthetic Devices - Pipeline Products by Stage of Development 19
  • Table 2: Aesthetic Devices - Pipeline Products by Segment 20
  • Table 3: Aesthetic Devices - Pipeline Products by Territory 21
  • Table 4: Aesthetic Devices - Pipeline Products by Regulatory Path 23
  • Table 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date 25
  • Table 6: Aesthetic Devices - Ongoing Clinical Trials 26
  • Table 7: Aesthetic Devices Companies - Pipeline Products by Stage of Development 27
  • Table 8: Aesthetic Devices - Pipeline Products by Stage of Development 30
  • Table 9: Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 10: Strattice For Facelift - Product Status 34
  • Table 11: Strattice For Facelift - Product Description 34
  • Table 12: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 13: BioDermal Filler - Product Status 35
  • Table 14: BioDermal Filler - Product Description 35
  • Table 15: Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 16: Alluris - Product Status 36
  • Table 17: Alluris - Product Description 36
  • Table 18: Skinlumina - Product Status 36
  • Table 19: Skinlumina - Product Description 37
  • Table 20: Aesthetics Point Ltd. Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 21: Juvence Implant - Product Status 38
  • Table 22: Juvence Implant - Product Description 38
  • Table 23: Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 24: JUVEDERM Volbella - Product Status 39
  • Table 25: JUVEDERM Volbella - Product Description 39
  • Table 26: VYC-25L Hyaluronic Acid Injectable Gel - Product Status 40
  • Table 27: VYC-25L Hyaluronic Acid Injectable Gel - Product Description 40
  • Table 28: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 29: Botox - Forehead Lines - Product Status 41
  • Table 30: Botox - Forehead Lines - Product Description 42
  • Table 31: Botox - Masseter - Product Status 42
  • Table 32: Botox - Masseter - Product Description 42
  • Table 33: earFold - Product Status 42
  • Table 34: earFold - Product Description 43
  • Table 35: Eplica Silk - Product Status 43
  • Table 36: Eplica Silk - Product Description 43
  • Table 37: HA Threads - Product Status 44
  • Table 38: HA Threads - Product Description 44
  • Table 39: Juvederm Volift - Nasolabial Folds - Product Status 44
  • Table 40: Juvederm Volift - Nasolabial Folds - Product Description 44
  • Table 41: MicroCell - Breast Augmentation - Product Status 45
  • Table 42: MicroCell - Breast Augmentation - Product Description 45
  • Table 43: Phoenix - Breast Augmentation - Product Status 45
  • Table 44: Phoenix - Breast Augmentation - Product Description 45
  • Table 45: SeriGel - Product Status 46
  • Table 46: SeriGel - Product Description 46
  • Table 47: Skin Quattro Device - Product Status 46
  • Table 48: Skin Quattro Device - Product Description 46
  • Table 49: Allergan Plc - Ongoing Clinical Trials Overview 47
  • Table 50: earFold - Long Term Prospective Uncontrolled Study of Earfold or the Treatment of Prominent Ears: FOLD 48
  • Table 51: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 52: Hyaluronic Acid Facial Filler - Product Status 49
  • Table 53: Hyaluronic Acid Facial Filler - Product Description 49
  • Table 54: Ambicare Health Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 55: Ambulight Rejuvenate - Product Status 50
  • Table 56: Ambulight Rejuvenate - Product Description 50
  • Table 57: Andrew Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 58: HydraSolve Lipoplasty System - Visceral Fat - Product Status 51
  • Table 59: HydraSolve Lipoplasty System - Visceral Fat - Product Description 51
  • Table 60: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 61: Next Generation ELEVESS Dermal Filler - Product Status 52
  • Table 62: Next Generation ELEVESS Dermal Filler - Product Description 52
  • Table 63: Avita Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 64: ReNovaCell - Aesthetics And Repigmentation - Product Status 53
  • Table 65: ReNovaCell - Aesthetics And Repigmentation - Product Description 53
  • Table 66: Avita Medical Ltd - Ongoing Clinical Trials Overview 54
  • Table 67: ReNovaCell - Aesthetics And Repigmentation - Autologous Cell Suspension Grafting Using ReNovacell in Non-segmental Vitiligo Patients: A Randomized Controlled Study 55
  • Table 68: BioPhotas, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 69: Celluma - Skin Rejuvenation And Sun Spots - Product Status 56
  • Table 70: Celluma - Skin Rejuvenation And Sun Spots - Product Description 56
  • Table 71: Biosculpture Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 72: Airbrush Liposculptor IIE - Product Status 57
  • Table 73: Airbrush Liposculptor IIE - Product Description 57
  • Table 74: Airbrush Liposculptor IIIE - Product Status 58
  • Table 75: Airbrush Liposculptor IIIE - Product Description 58
  • Table 76: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 77: Renevia - Product Status 59
  • Table 78: Renevia - Product Description 60
  • Table 79: BioTime Inc - Ongoing Clinical Trials Overview 61
  • Table 80: Renevia - A Randomized, Evaluator-blinded, Delayed-treatment-controlled Study of the Effectiveness and Safety of Renevia, A Resorbable Matrix for the Delivery of Autologous Adipose Derived Cells to treat Subcutaneous Facial Lipoatrophy Defects Arising from HIV 62
  • Table 81: Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 82: CYTOSIAL Deep Wrinkle - Product Status 63
  • Table 83: CYTOSIAL Deep Wrinkle - Product Description 63
  • Table 84: CYTOSIAL Medium - Product Status 64
  • Table 85: CYTOSIAL Medium - Product Description 64
  • Table 86: Cytosial Volume - Product Status 64
  • Table 87: Cytosial Volume - Product Description 64
  • Table 88: Cytosmile - Product Status 65
  • Table 89: Cytosmile - Product Description 65
  • Table 90: MTI-12 - Product Status 65
  • Table 91: MTI-12 - Product Description 66
  • Table 92: MTI-12 - Aesthetic Device - Product Status 66
  • Table 93: MTI-12 - Aesthetic Device - Product Description 66
  • Table 94: MTI-12 - Surgical Repair - Product Status 66
  • Table 95: MTI-12 - Surgical Repair - Product Description 67
  • Table 96: Bovie Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 97: Renuvion - Dermal Resurfacing - Product Status 68
  • Table 98: Renuvion - Dermal Resurfacing - Product Description 68
  • Table 99: Bovie Medical Corp - Ongoing Clinical Trials Overview 69
  • Table 100: Renuvion - Dermal Resurfacing - A Prospective, Multicenter, Single Arm Clinical Study Evaluating the Use of J-Plasma for Dermal Resurfacing 70
  • Table 101: Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 102: Credurance - Product Status 71
  • Table 103: Credurance - Product Description 71
  • Table 104: CollPlant Ltd Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 105: Next Generation Dermal Filler - Product Status 72

1.2 List of Figures

  • Figure 1: Aesthetic Devices - Pipeline Products by Stage of Development 19
  • Figure 2: Aesthetic Devices - Pipeline Products by Segment 20
  • Figure 3: Aesthetic Devices - Pipeline Products by Territory 21
  • Figure 4: Aesthetic Devices - Pipeline Products by Regulatory Path 23
  • Figure 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date 25
  • Figure 6: Aesthetic Devices - Ongoing Clinical Trials 26
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research